Treatment Strategies for Obesity
Journal Title: Міжнародний ендокринологічний журнал - Year 2013, Vol 4, Issue 52
Abstract
Obesity is a disease that is defined as the accumulation of excessive amounts of body fat and is associated with increased risk of serious illness, disability, and death. Treatment options are determined based on the body mass index, waist circumference, and adverse health consequences the patient is experiencing or is at an increased risk for facing in the future. Although endocrinologists are uniquely positioned to treat one of the major consequences of our current obesity epidemic, type 2 diabetes, we also need to be positioned and prepared to effectively treat one of its major causes — obesity. Type 2 diabetes and obesity are very much intertwined. Treatment of each disease affects the other. For these reasons, endocrinologists need to be experts in the treatment of obesity as well as diabetes. They should keep up with advances in obesity treatment including lifestyle, pharmaceutical, and surgical strategies. These strategies offer opportunities for improving the overall treatment for our obese patients today and will continue to improve and expand over the next decade.
Authors and Affiliations
V. Pankiv
Keywords
Related Articles
- EP ID EP233112
- DOI -
- Views 40
- Downloads 0
Combined oral contraceptives: the optimal range of examination. Part 1
Combined oral contraceptives are effective drugs for contraception and treatment of reproductive disorders in polycystic ovarian syndrome. The article considers the main laboratory algorithms for excluding the most commo...
Rational Prescribing of Sulfonylurea in Patients with Diabetes Mellitus Type 2
No abstract
Hypopituitarism in Children. Modern Laboratory and Genetic Diagnosis
The lecture presents the current international guidelines on the diagnosis of hypopituitarism in children, in particular the rules of stimulation tests for the diagnosis of growth hormone deficiency, secondary hypogonadi...
New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin del...
Central Diabetes Insipidus
The lecture presents modern data on epidemiology, etiology, pathogenesis, diagnosis and treatment of central diabetes insipidus.